MR spectroscopy of cerebral white matter in type 2 diabetes; No association with clinical variables and cognitive performance

Neuroradiology

Volumn 52, Issue 2, 2010, Pages 155-161

  Tiehuis, Audrey ^a   Van Der Meer, Femke ^a   Mali, Willem ^a   Pleizier, Marc ^b   Biessels, Geert Jan ^b   Kappelle, Jaap ^b   Luijten, Peter ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Cognition; Single voxel proton magnetic resonance spectroscopy; Type 2 diabetes

Indexed keywords

CHOLINE; CREATINE; N ACETYLASPARTIC ACID;

ADULT; AGED; ARTICLE; BRAIN METABOLISM; BRAIN NERVE CELL; CELL VIABILITY; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MEMORY; NERVE CELL MEMBRANE; NEUROPSYCHOLOGICAL TEST; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTON NUCLEAR MAGNETIC RESONANCE; WHITE MATTER;

AGED; AGED, 80 AND OVER; ASPARTIC ACID; BRAIN; CHOLINE; COGNITION; COGNITION DISORDERS; CREATINE; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MEMORY; MIDDLE AGED; NERVE FIBERS, MYELINATED; NEUROPSYCHOLOGICAL TESTS; PHOTONS; TIME FACTORS;

EID: 77949272202     PISSN: 00283940     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00234-009-0598-4     Document Type: Article

References (24)

1. R Stewart D Liolitsa 1999 Type 2 diabetes mellitus, cognitive impairment and dementia Diabet Med 16 93 112 10.1046/j.1464-5491.1999.00027.x 1:STN:280:DyaK1M3ksVejug%3D%3D 10229302
2. KV Allen BM Frier MW Strachan 2004 The relationship between type 2 diabetes and cognitive dysfunction: longitudinal studies and their methodological limitations Eur J Pharmacol 490 169 175 10.1016/j.ejphar.2004.02. 054 1:CAS:528:DC%2BD2cXjt1Shtr4%3D 15094083 (Pubitemid 38482170)
3. B van Harten FE de Leeuw HC Weinstein P Scheltens GJ Biessels 2006 Brain imaging in patients with diabetes: a systematic review Diabetes Care 29 2539 2548 10.2337/dc06-1637 17065699 (Pubitemid 44912267)
4. MU Di S Morano E Valle G Pozzessere 1995 Electrophysiological alterations of the central nervous system in diabetes mellitus Diabetes Metab Rev 11 259 277 10.1002/dmr.5610110306
5. Z Lackovic M Salkovic Z Kuci M Relja 1990 Effect of long-lasting diabetes mellitus on rat and human brain monoamines J Neurochem 54 143 147 10.1111/j.1471-4159.1990.tb13294.x 1:CAS:528:DyaK3cXltlaisg%3D%3D 2293606 (Pubitemid 20026107)
6. SM Manschot AM Brands J van der Grond RP Kessels A Algra LJ Kappelle GJ Biessels 2006 Brain magnetic resonance imaging correlates of impaired cognition in patients with type 2 diabetes Diabetes 55 1106 1113 10.2337/diabetes.55.04. 06.db05-1323 1:CAS:528:DC%2BD28XjsVGmtbg%3D 16567535 (Pubitemid 44100188)
7. Williams SR (1992) In vivo proton spectroscopy: experimental aspects and potential. In: Rudin M (ed) NMR basic principles and progress. Springer, Berlin, pp 55-71
8. K Kantarci CR Jack Jr YC Xu NG Campeau PC O'Brien GE Smith RJ Ivnik BF Boeve E Kokmen EG Tangalos RC Petersen 2000 Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: a 1H MRS study Neurology 55 210 217 1:CAS:528:DC%2BD3cXlvVymt70%3D 10908893
9. L Parnetti R Tarducci O Presciutti DT Lowenthal M Pippi B Palumbo G Gobbi GP Pelliccioli U Senin 1997 Proton magnetic resonance spectroscopy can differentiate Alzheimer's disease from normal aging Mech Ageing Dev 97 9 14 10.1016/S0047-6374(97)01877-0 1:CAS:528:DyaK2sXksVWjur0%3D 9223122 (Pubitemid 27279860)
10. M Catani A Cherubini R Howard R Tarducci GP Pelliccioli M Piccirilli G Gobbi U Senin P Mecocci 2001 (1)H-MR spectroscopy differentiates mild cognitive impairment from normal brain aging NeuroReport 12 2315 2317 10.1097/00001756- 200108080-00007 1:CAS:528:DC%2BD3MXmtVOmu7c%3D 11496102
11. A Metastasio P Rinaldi R Tarducci E Mariani FT Feliziani A Cherubini GP Pelliccioli G Gobbi U Senin P Mecocci 2006 Conversion of MCI to dementia: role of proton magnetic resonance spectroscopy Neurobiol Aging 27 926 932 10.1016/j.neurobiolaging.2005.05.002 1:CAS:528:DC%2BD28XkvVOnsbY%3D 15936850
12. O Ajilore E Haroon S Kumaran C Darwin N Binesh J Mintz J Miller MA Thomas A Kumar 2007 Measurement of brain metabolites in patients with type 2 diabetes and major depression using proton magnetic resonance spectroscopy Neuropsychopharmacology 32 1224 1231 10.1038/sj.npp.1301248 1:CAS:528: DC%2BD2sXltlaqtLc%3D 17180124 (Pubitemid 46788852)
13. A Geissler R Frund J Scholmerich S Feuerbach B Zietz 2003 Alterations of cerebral metabolism in patients with diabetes mellitus studied by proton magnetic resonance spectroscopy Exp Clin Endocrinol Diabetes 111 421 427 10.1055/s-2003-44289 1:CAS:528:DC%2BD3sXpsFalt7g%3D 14614649 (Pubitemid 37486434)
14. K Kario J Ishikawa S Hoshide Y Matsui M Morinari K Eguchi S Ishikawa K Shimada 2005 Diabetic brain damage in hypertension: role of renin-angiotensin system Hypertension 45 887 893 10.1161/01.HYP.0000163460.07639.3f 1:CAS:528:DC%2BD2MXjtlymu7c%3D 15824198 (Pubitemid 40628933)
15. R Kreis BD Ross 1992 Cerebral metabolic disturbances in patients with subacute and chronic diabetes mellitus: detection with proton MR spectroscopy Radiology 184 123 130 1:STN:280:DyaK38zgt1GjsA%3D%3D 1319074
16. S Modi M Bhattacharya T Sekhri P Rana RP Tripathi S Khushu 2008 Assessment of the metabolic profile in type 2 diabetes mellitus and hypothyroidism through proton MR spectroscopy Magn Reson Imaging 26 420 425 10.1016/j.mri.2007.08.011 1:CAS:528:DC%2BD1cXjtVertr0%3D 18164573
17. I Sahin A Alkan L Keskin A Cikim HM Karakas AK Firat A Sigirci 2008 Evaluation of in vivo cerebral metabolism on proton magnetic resonance spectroscopy in patients with impaired glucose tolerance and type 2 diabetes mellitus J Diabetes its Complications 22 254 260 10.1016/j.jdiacomp.2007.03.007 (Pubitemid 351885485)
18. R Klein BE Klein YL Magli RJ Brothers SM Meuer SE Moss MD Davis 1986 An alternative method of grading diabetic retinopathy Ophthalmology 93 1183 1187 1:STN:280:DyaL2s7hs12rsQ%3D%3D 3101021
19. V Bril BA Perkins 2002 Validation of the Toronto Clinical Scoring System for diabetic polyneuropathy Diabetes Care 25 2048 2052 10.2337/diacare.25.11. 2048 12401755 (Pubitemid 41071067)
20. P Anbeek KL Vincken GS van Bochove MJ van Osch J van der Grond 2005 Probabilistic segmentation of brain tissue in MR imaging Neuroimage 27 795 804 10.1016/j.neuroimage.2005.05.046 16019235 (Pubitemid 41317249)
21. PA Bottomley 1987 Spatial localization in NMR spectroscopy in vivo Ann N Y Acad Sci 508 333 348 10.1111/j.1749-6632.1987.tb32915.x 1:STN:280: DyaL1c7kvVKqtw%3D%3D 3326459
22. van den Boogaart A (1997) A user's guide to the magnetic resonance user interface software package. Delft Technical University Press, Delft
23. Lezak MD, Howieson DB, Loring DW (2004). Neuropsychological Assessment (4th ed.). New York: Oxford University press
24. P Bright E Jaldow MD Kopelman 2002 The national adult reading test as a measure of premorbid intelligence: a comparison with estimates derived from demographic variables J Int Neuropsychol Soc 8 847 854 10.1017/S1355617702860131 12240749